Not exact matches
Palbociclib blocks a major alternate route, called the CDK4 / 6 growth signal, by
inhibiting cancer cell
proliferation and
cellular division.
Because sorafenib
inhibits the chemical signals that can trigger both
cellular proliferation and new blood vessel growth, Gomberg - Maitland and colleagues suspected it might slow the growth and thickening of the pulmonary artery walls.
Trastuzumab directly
inhibits the
proliferation of HER2 - overexpressing breast cancer cells and induces immune - mediated killing of target cancer cells through antibody - dependent
cellular cytotoxicity [20].